TOP特許意匠商標
商標ウォッチ Twitter
公開日2025-03-12
公報種別公開国際商標公報
国際登録番号1831510
国際登録日2024-11-08
区分第5類(薬剤),第42類(科学・技術),第44類(医療・農林業)
商品役務Pharmaceutical and medical preparations and products, biological medical and pharmaceutical preparations and products; pharmaceutical and biological preparations for medical use, namely nucleic acids, proteins, protein conjugates, peptides, attenuated viruses, viral vectors and vector constructions; biological tissue cultures for medical use; biological tissue cultures intended for use in the diagnosis, prevention and treatment of diseases, in particular eye diseases; biological tissue cultures intended for use in gene therapy treatments.,Scientific and technological services as well as research and design services relating thereto; quality control and authentication services; design and development of computers and software; research and development services in the fields of molecular biology, biotechnology, pharmacy and medicine; research and development services in the fields of molecular biology, biotechnology, pharmacy and medicine, in particular in the field of eye diseases; research and development services in the field of medical diagnostics, prophylaxis and therapy, in particular gene therapy; research services全 29 件を表示, namely examination and research of compounds and components intended for therapeutic or diagnostic use, in particular intended for use in relation to eye diseases; research services in the field of gene therapy; developing protocols, technical planning, advice and services in the fields of molecular biology, biotechnology and pharmacy, in particular intended for use in the field of ocular diseases and gene therapies.,Medical services; medical services, namely medical diagnosis through molecular biology, genetic engineering and biotechnology methods, in particular in the field of eye diseases; therapy services, in particular gene therapy.
基礎出願番号
基礎出願日
基礎出願国
出願人RhyGaze AG
OCRテキストKRKHYGAZE
OCRテキスト2
OCRについて
この商標をJ-PlatPatで参照する
Flag Counter

関連商標

RhyGaze AG
今日
NOVARTIS AG
1か月前
Atara Biotherapeutics, Inc.
13日前
OFD BioPharma, LLC
1か月前
Boehringer Ingelheim Vetmedica GmbH
7日前
SOLETLUNA HOLDINGS, INC.
1か月前
Novartis AG
27日前
Roche Diagnostics GmbH
LUMIRA
20日前
IGNAZIO LOI
27日前
Boehringer Ingelheim Vetmedica GmbH
7日前
FIN-CERAMICA FAENZA S.p.A.
27日前
F. Hoffmann-La Roche AG
13日前
SIGNS
7日前
Instylla, Inc.
1か月前
Boehringer Ingelheim Vetmedica GmbH
7日前
Avava, Inc.
1か月前
SANOFI BIOTECHNOLOGY
13日前
SANOFI BIOTECHNOLOGY
13日前
Boehringer Ingelheim Vetmedica GmbH
7日前
Celsius Holdings, Inc.
1か月前
VIRBAC
13日前
CPTx GmbH
1か月前
SIGNS
7日前
Wonbiogen Co., Ltd.
1か月前
Roche Diagnostics GmbH
13日前
Astrasana Animal Health AG
7日前
MedinCell S.A.
今日
Novartis AG
7日前
GlaxoSmithKline Biologicals S.A.
7日前
Fourflax Limited
7日前
NEW ZEALAND AGAHEALTH INTERNATIONAL LIMITED
7日前
3H LABS Co.,Ltd.
今日
Velinor AG c/o Dr. iur. Adrian von Segesser
20日前
CHOI, Yeo Reum
20日前
BeiGene Switzerland GmbH
7日前
EyePoint Pharmaceuticals US, Inc.
1か月前
続きを見る